| Particulars (Rupees in Crores.) | Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 |
|---|---|---|---|---|---|
Gross Sales | 2,269 | 2,098 | 1,973 | 2,575 | 2,076.34 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 2,269 | 2,098 | 1,973 | 2,575 | 2,076.34 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 47 | 31 | 102 | 9 | 1,466.44 |
Total Income | 2,316 | 2,129 | 2,075 | 2,584 | 3,542.78 |
Total Expenditure | 1,940 | 1,972 | 2,085 | 2,247 | 2,073.31 |
PBIDT | 376 | 157 | -10 | 337 | 1,469.47 |
Interest | 206 | 232 | 226 | 213 | 194.45 |
PBDT | 170 | -75 | -236 | 124 | 1,275.02 |
Depreciation | 164 | 165 | 195 | 188 | 180.99 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 6 | 14 | 10 | 37 | 223.08 |
Deferred Tax | 12 | 41 | -57 | -133 | 75.51 |
Reported Profit After Tax | -12 | -295 | -384 | 32 | 795.44 |
Minority Interest After NP | 10 | -1 | -32 | 18 | 16.59 |
Net Profit after Minority Interest | -22 | -294 | -352 | 14 | 778.85 |
Extra-ordinary Items | 0 | -10.79 | -190.48 | 0 | 1,327.84 |
Adjusted Profit After Extra-ordinary item | -22 | -283.21 | -161.52 | 14 | -548.99 |
EPS (Unit Curr.) | -1.41 | -20.4 | -24.42 | 1.17 | 70.33 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 81 | 72 | 72 | 55 | 55.39 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 16.57 | 7.48 | -0.5 | 13.08 | 70.77 |
PBDTM(%) | 7.49 | -3.57 | -11.96 | 4.81 | 61.4 |
PATM(%) | -0.52 | -14.06 | -19.46 | 1.24 | 38.3 |
WCK 6777 is the only once-a-day antibiotic in the global pipeline designated for outpatient parenteral antimicrobial therapy (OPAT).
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
